Posts in tag

asthma


PDL has issued advice on salbutamol and changes to the S3 supply requirements PDL has spoken with many pharmacists impacted by the changes to S3 supply requirements for salbutamol inhalers …

Debbie Rigby takes a look at the latest in research news Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure The EMPEROR-Reduced Trial compared empagliflozin (10 mg once daily) or …

Debbie Rigby rounds up the latest in research news Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates In this large cohort study, the risk of atypical femur fracture …

Debbie Rigby rounds up the latest in research news   Association Between Beliefs and Adherence to Inhaled Controller Medication Among Older Adults with Asthma In this questionnaire with older patients …

Proposal for combination asthma inhalers to be downscheduled to Pharmacist Only with Appendix M controls for ‘as needed’ use A request has been made for the TGA to downschedule budesonide-formoterol …

New edition of National Asthma Handbook is launched The National Asthma Council Australia has today (26 August) launched the latest edition of the Australian Asthma Handbook V2.1  – which outlines …

Ventolin inhalers with a dose counter are now listed on the PBS, with a full transition to the new design expected by end of 2020 A dose counter has been …

While GSK is prioritising supply of salbutamol to hospital pharmacies, there are good stock levels of the medicine across the country There have been anecdotal reports of an increased demand …

Complaints about declining supply of medicine are on the rise, complicated by consumer behaviour thanks to COVID-19… what strategies can pharmacists use to manage the problem? PDL says that one …

A new pre-filled autoinjector for at-home administration of mepolizumab will be reimbursed by the PBS from 1 June Patients with severe refractory eosinophilic asthma can now choose to receive treatment …

Symbicort is now PBS-listed for any form of asthma severity – mild, moderate or severe. So how should this change your conversations with patients asking for an OTC blue puffer? …

Debbie Rigby takes a look at the latest in research news Checking Inhaler Technique in the Community Pharmacy: Predictors of Critical Errors Up to 92% of patients demonstrate at least …